A study protocol is designed to measure adherence to SSE, cost, and resource management, as well as to determine the usefulness of polarized vs nonpolarized dermoscopy devices.
Outcomes have improved during the past decade for patients with acute lymphoblastic leukemia who undergo haploidentical hematopoietic cell transplantation.
Researchers sought to investigate the associations between PTSS and the experiences of pediatric survivors of Hodgkin lymphoma treated in the AHOD0031 study.
Greater examination aided in accurate staging and improved survival in pure-solid, non-small cell lung cancer.
Bone modifying agents had no effect on survival outcomes.
Multiple myeloma is an uncommon form of cancer, and one that may not produce symptoms right away. Because of this, patients with higher risk due to family history, exposure, or other reasons may need more education about it. How can you explain multiple myeloma to your patients?
Early radiotherapy may preserve visual acuity for certain children with sporadic optic pathway/hypothalamic gliomas.
Baseline alcohol consumption was associated with a higher QOL score compared with never use of alcohol.
Researchers assessed the characteristics that most influence parents’ decision regarding allowing their child to participate in a clinical trial.
GPS can predict adverse outcomes in men with prostate cancer and may be used to select patients for active surveillance rather than active treatment.
Therapeutic combinations of immune checkpoint blockade with targeted, oncolytic, or antiangiogenic approaches are promising for patients with cutaneous melanoma.
A decrease in obesity rates may reduce the burden of gallbladder and biliary tract cancer worldwide, according to the results of a study.
A review of retrospective data sought to better understand the relationship between obesity and survival in renal cell carcinoma.
Researchers sought to determine the effectiveness of venetoclax combinations to improve survival to SCT eligibility in patients with AML as a complication of myeloproliferative neoplasm.
Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators.
Changes 2 to 4 months after the start of therapy with pembrolizumab may predict long-term response and survival.
Gene expression analysis and the identification of a single gene or a signature correlated with patients’ outcomes could lead to improved patient stratification.
Researchers findings support the use of pembrolizumab in patients with resected stage III melanoma.
Researchers sought to identify frailty assessment tools and determine which are effective in patients undergoing hematopoietic stem cell transplantation.
Results of a retrospective cohort study shows the impact of COVID-19 pandemic on screening rates for breast, prostate, and colorectal cancer.